MPO and chronic granulomatous disease: The disparity in the clinical manifestations of CGD, where patients suffer significant infection‐related morbidity and mortality, and MPO deficiency, which somewhat surprisingly goes largely unnoticed, questions the predominance of a single killing mechanism.